Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
Notification and public disclosure of transactions by persons discharging managerial responsibilities
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Michael Raya |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
CEO of West-Ward Pharmaceuticals |
|
b) |
Initial notification /Amendment |
Amendment |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction |
Purchase of 10,272 shares in the Company in compliance with the Company's shareholding requirement. |
|
c) |
Price(s) and volume(s) |
Price(s): £18.689 Volume(s): 10,272 |
|
d) |
Aggregated information |
Price(s): £18.689 Total: £191,973.41 |
|
e) |
Date of the transaction |
26 April 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN